Alfredo Addeo MD (@Alfdoc2)

Alfredo Addeo MD Retweeted

O

OncoDaily@oncodaily · Jul 18

We would like to inform you that your post has been published on OncoDaily.com. Thank you for sharing. oncodaily.com/science/target…

0

2

3

0

188

Alfredo Addeo MD Retweeted

E

ESMO Open@ESMO_Open · Jul 24

Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis in @ESMO_Open. 229 pts, 169 treated with 1st line Tx, 68.6% PD-L1 high, 39.7% KRAS mut. Longer PFS and OS with ICIs+/-CT as compared to CT alone. esmoopen.com/article/S2059-…

1

23

47

18

6.0K

Alfredo Addeo MD Retweeted

I

International Lung Cancer Summit@LungSummit · Jul 23

Two powerful perspectives. One critical decision. In this high-stakes debate @tnewsomdavis defends osimertinib, while @LeXiuning makes the case for amivantamab + lazertinib. What’s the smarter frontline strategy in EGFR+ metastatic NSCLC? Join the ILCS on 26ᵗʰ September & decide

1

6

16

4

575

Alfredo Addeo MD Retweeted

I

International Lung Cancer Summit@LungSummit · Jul 22

@stephanieplsaw from Singapore will present the latest advances in targeting HER2 and MET in NSCLC – highlighting how new strategies are tackling resistance mutations and expanding the reach of precision oncology. Come to the ILCS and gain fresh clinical insights ⬇️

0

7

15

3

452

Alfredo Addeo MD Retweeted

d

d.planchard@dplanchard · Apr 9, 2024

FLAURA2- Baseline detection of ctDNA may identify a subgroup of pts who derive most benefit from addition of chemoT to osimertinib as first line trtt for EGFRmut NSCLC by P.Jänne at #AACR24 @EGFRResisters @DFEGFRcenter @GustaveRoussy @DanaFarberNews

3

43

97

25

9.0K

Alfredo Addeo MD Retweeted

R

Rami EdgeLord@KhouryHopes · Jul 21

Impressive! This review on EGFR mutant NSCLC will surely guide targeted cancer therapies. Well done, team! 🌟

0

1

2

0

249

A

Alfredo Addeo MD@Alfdoc2 · Jul 20

A state-of-the-art Review on #EGFR mutant #NSCLC in the most prestigious journal in the world. A must-read for all thoracic oncologists! I enjoyed every single 📖 Congratulations @Alfdoc2 @LeXiuning @stephanieplsaw @gbanna74 and all co-authors, this will be the reference paper…

AAlfredo Addeo MD@Alfdoc2 · Jul 17

Hot off the press a 🚨 Must-read review on optimizing treatment for #LungCancer with activating EGFR mutations , a true game changer in targeted therapy. TKIs have transformed outcomes, but the journey continues. 👉 acsjournals.onlinelibrary.wiley.com/doi/full/10.33… thanks to all the co-authors, great team…

2

7

20

2

2.0K

Alfredo Addeo MD Retweeted

T

Timothée Olivier, MD@Timothee_MD · Jul 19

A thoughtful and responsible decision by @DrMakaryFDA @VPrasadMDMPH @US_FDA after a third death potentially linked to Sarepta's products. “Protecting patient safety is our highest priority, and the FDA will not allow products whose harms are greater than benefits. The FDA will…

3

5

20

3

3.0K

A

Alfredo Addeo MD@Alfdoc2 · Jul 18

Whatever you want to know about #EGFR-addicted lung cancer, from the very beginning to today, you’ll find it in this masterpiece. It’s been a real privilege to collaborate on this project. @Maxime_Borgeaud @Timothee_MD @JairBar4 @kaushalpar @jillfeldman4 @LeXiuning @Alfdoc2

CCA: A Cancer Journal for Clinicians@CACancerJournal · Jul 17

Activating mutations in EGFR gene has revolutionized management of #LungCancer, enabling development of TKIs. New review on strategies to optimize treatment: acsjournals.onlinelibrary.wiley.com/doi/full/10.33… @Alfdoc2 @Maxime_Borgeaud @Timothee_MD @JairBar4 @kaushalpar @jillfeldman4 @LeXiuning @OncoAlert

0

20

45

13

4.0K

A

Alfredo Addeo MD@Alfdoc2 · Jul 18

Fantastic work together with @Alfdoc2 @jillfeldman4 and my global colleagues. Now we have identified clinical and molecular poor prognostic factors, we just have to push forward to improve outcomes for those patients. @MDAndersonNews @lungoncdoc @OncoViews @oncodaily

AAlfredo Addeo MD@Alfdoc2 · Jul 17

Hot off the press a 🚨 Must-read review on optimizing treatment for #LungCancer with activating EGFR mutations , a true game changer in targeted therapy. TKIs have transformed outcomes, but the journey continues. 👉 acsjournals.onlinelibrary.wiley.com/doi/full/10.33… thanks to all the co-authors, great team…

0

8

29

2

2.0K

Alfredo Addeo MD Retweeted

J

Jill Feldman@jillfeldman4 · Jul 18

Calling all #thoracic #oncology leaders! We’re inviting early career investigators to submit an abstract for a chance to join us at the 7th Annual EGFR Resisters Research Summit @EGFRSummit, (Nov 6–8 in Chicago). Please share this opportunity with your fellows, postdocs, or…

1

9

22

0

1.0K

A

Alfredo Addeo MD@Alfdoc2 · Jul 17

Hot off the press a 🚨 Must-read review on optimizing treatment for #LungCancer with activating EGFR mutations , a true game changer in targeted therapy. TKIs have transformed outcomes, but the journey continues. 👉 acsjournals.onlinelibrary.wiley.com/doi/full/10.33… thanks to all the co-authors, great team…

CCA: A Cancer Journal for Clinicians@CACancerJournal · Jul 17

Activating mutations in EGFR gene has revolutionized management of #LungCancer, enabling development of TKIs. New review on strategies to optimize treatment: acsjournals.onlinelibrary.wiley.com/doi/full/10.33… @Alfdoc2 @Maxime_Borgeaud @Timothee_MD @JairBar4 @kaushalpar @jillfeldman4 @LeXiuning @OncoAlert

6

26

69

21

10.0K

Alfredo Addeo MD Retweeted

R

Rɪᴏʏᴇ Aᴜꜱᴋ@Polarbear900R · Jul 16

Next-In-Class vs Original Oncology Drugs jamanetwork.com/journals/jamai…

0

2

3

1

203

Alfredo Addeo MD Retweeted

S

Stephen V Liu, MD@StephenVLiu · Jul 16

Tonight - July 16 - 5pm EST. Join Dr. @charlesrudin and me with @DrNeilLove in this practical #SCLC webinar. Free registration for a robust, case based discussion in a space with rapid shifts in standards of care! researchtopractice.com/Webinars/PP/SC…

1

2

33

0

2.0K

Alfredo Addeo MD Retweeted

I

International Lung Cancer Summit@LungSummit · Jul 15

Meet our first speaker at the ILCS: @md_mariusilie from France. Join us on 26ᵗʰ September with our chairs @Alfdoc2 & @peters_solange as he explores how cutting-edge diagnostic techniques and emerging tools are transforming lung cancer care. ⬇️ Register Now

1

5

17

4

554

Alfredo Addeo MD Retweeted

E

ESMO - Eur. Oncology@myESMO · Jul 15

📣 #ESMO25: Be where the latest breakthroughs are being shared—in real time, with real impact. Last chance to register at the most advantageous fees! ⏰ Deadline: 16 July 2025 🔗 ow.ly/5PAL50WfVKu

1

8

29

1

4.0K

Alfredo Addeo MD Retweeted

E

ESMO - Eur. Oncology@myESMO · Jul 8

👉 The ESMO Asia Congress 2025 takes place in Singapore, 5–7 December. Connect with oncology professionals and explore the latest developments for cancer care in the region. ⏰Early registration is available until 3 September. #ESMOAsia25 🔗 ow.ly/vJV450WjOFm

0

4

7

0

1.0K

Alfredo Addeo MD Retweeted

T

Timothée Olivier, MD@Timothee_MD · Jul 14

x.com/i/article/1944…

4

43

147

87

27.0K

Alfredo Addeo MD Retweeted

I

International Lung Cancer Summit@LungSummit · Jun 2

Registration is now open for the 7th International Lung Cancer Summit #ILCS25! Connect with our hosts, @Alfdoc2 & @peters_solange, and leading experts to get the latest developments in thoracic oncology 🫁 🗓️ 26 September from 9:30AM CEST ⬇️ Secure your seat early

1

11

20

3

2.0K

Alfredo Addeo MD Retweeted

L

Lung Cancers Today@Lung_Cancers · Jul 12

🫁 How are IMFORTE and DeLLphi-304 changing the standard of care for SCLC? 🌟 In this insightful new interview, @StephenVLiu unpacks the #ASCO25 data and what it means for the treatment landscape. ➡️ Watch now: buff.ly/Hh4YzLi #lcsm #SCLC #ASCO2025

2

12

40

18

4.0K